These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor. Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020 [TBL] [Abstract][Full Text] [Related]
7. p16 expression in the female genital tract and its value in diagnosis. O'Neill CJ; McCluggage WG Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152 [TBL] [Abstract][Full Text] [Related]
8. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma]. Wu HW; Liu TH Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346 [No Abstract] [Full Text] [Related]
9. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas. Zhang L; Liu Y; Hao S; Woda BA; Lu D Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514 [TBL] [Abstract][Full Text] [Related]
10. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis. McCluggage WG; Connolly LE; McBride HA; Kalloger S; Gilks CB Histopathology; 2012 Mar; 60(4):547-53. PubMed ID: 22250726 [TBL] [Abstract][Full Text] [Related]
11. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
12. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin. Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724 [TBL] [Abstract][Full Text] [Related]
13. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells. Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium. Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416 [TBL] [Abstract][Full Text] [Related]
17. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma. Huang W; Cheng X; Ji J; Zhang J; Li Q Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716 [TBL] [Abstract][Full Text] [Related]